TrialJournal of translational medicine2018

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Neil H Riordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.